NO963000D0 - Bedret fordöyelighet av farmasöytisk virksomme -aminosyrer - Google Patents

Bedret fordöyelighet av farmasöytisk virksomme -aminosyrer

Info

Publication number
NO963000D0
NO963000D0 NO963000A NO963000A NO963000D0 NO 963000 D0 NO963000 D0 NO 963000D0 NO 963000 A NO963000 A NO 963000A NO 963000 A NO963000 A NO 963000A NO 963000 D0 NO963000 D0 NO 963000D0
Authority
NO
Norway
Prior art keywords
amino acids
pharmaceutically active
active amino
improved digestibility
digestibility
Prior art date
Application number
NO963000A
Other languages
English (en)
Other versions
NO315926B1 (no
NO963000L (no
Inventor
Michael Matzke
Hans-Christian Militzer
Joachim Mittendorf
Franz Kunisch
Axel Schmidt
Wolfgang Schonfeld
Karl Ziegelbauer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO963000D0 publication Critical patent/NO963000D0/no
Publication of NO963000L publication Critical patent/NO963000L/no
Publication of NO315926B1 publication Critical patent/NO315926B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19963000A 1995-07-19 1996-07-18 Antimikrobielt aktive blandinger, legemidler inneholdende disse samt anvendelse av blandingene for fremstilling av legemidler NO315926B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19526274A DE19526274A1 (de) 1995-07-19 1995-07-19 Verbesserung der Verträglichkeit von pharmazeutisch wirksamen beta-Aminosäuren

Publications (3)

Publication Number Publication Date
NO963000D0 true NO963000D0 (no) 1996-07-18
NO963000L NO963000L (no) 1997-01-20
NO315926B1 NO315926B1 (no) 2003-11-17

Family

ID=7767189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963000A NO315926B1 (no) 1995-07-19 1996-07-18 Antimikrobielt aktive blandinger, legemidler inneholdende disse samt anvendelse av blandingene for fremstilling av legemidler

Country Status (45)

Country Link
US (1) US5935988A (no)
EP (2) EP1043332B1 (no)
JP (2) JP3891503B2 (no)
KR (1) KR100433968B1 (no)
CN (1) CN1115145C (no)
AR (1) AR003465A1 (no)
AT (2) ATE198469T1 (no)
AU (1) AU713555B2 (no)
BG (1) BG62134B1 (no)
BR (1) BR9603124A (no)
CA (1) CA2181308A1 (no)
CO (1) CO4700525A1 (no)
CU (1) CU22820A3 (no)
CZ (2) CZ287896B6 (no)
DE (3) DE19526274A1 (no)
DK (2) DK0754678T3 (no)
DZ (1) DZ2073A1 (no)
EE (1) EE03803B1 (no)
ES (2) ES2275460T3 (no)
GR (1) GR3035601T3 (no)
HK (1) HK1005131A1 (no)
HR (1) HRP960303B1 (no)
HU (1) HUP9601977A3 (no)
IL (1) IL118869A (no)
MA (1) MA23940A1 (no)
MX (1) MX9602836A (no)
NO (1) NO315926B1 (no)
NZ (1) NZ299008A (no)
PE (1) PE9398A1 (no)
PL (1) PL184861B1 (no)
PT (2) PT1043332E (no)
RO (1) RO118656B1 (no)
RS (1) RS49520B (no)
RU (1) RU2181123C2 (no)
SA (1) SA96170491B1 (no)
SG (1) SG47158A1 (no)
SI (2) SI1043332T1 (no)
SK (2) SK281850B6 (no)
SV (1) SV1996000062A (no)
TN (1) TNSN96100A1 (no)
TR (1) TR199600583A2 (no)
TW (1) TW496737B (no)
UA (1) UA46725C2 (no)
YU (1) YU20050685A (no)
ZA (1) ZA966111B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191306B1 (en) * 1999-08-03 2001-02-20 Eastman Chemical Company Process for the preparation of cyclopropylglycine
KR20010073441A (ko) * 2000-01-14 2001-08-01 최인도 패류종묘 착상판의 제조방법
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7659253B2 (en) 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
SI1644019T2 (en) * 2003-05-29 2018-04-30 Shire Llc AMPHETAMINE COMPOUNDS COMPOUNDS TO ABUSE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716278D0 (en) * 1987-07-10 1987-08-19 Fujisawa Pharmaceutical Co Antimicrobial agent
JPH02174753A (ja) * 1988-08-25 1990-07-06 Fujisawa Pharmaceut Co Ltd シス―２―アミノシクロペンタンカルボン酸誘導体およびその製法ならびに抗菌剤
AU673824B2 (en) * 1992-05-29 1996-11-28 Bayer Aktiengesellschaft Cyclopentane- and -pentene-beta-amino acids
DE4302155A1 (de) * 1993-01-27 1994-07-28 Bayer Ag Verwendung von Cyclopentan- und -penten-beta-Aminosäuren
US5631291A (en) * 1992-05-29 1997-05-20 Bayer Aktiengesellschaft Cyclopentane- and -pentene-β-amino acids
GB9216441D0 (en) * 1992-08-03 1992-09-16 Ici Plc Fungicidal process
WO1995007022A1 (en) * 1993-09-07 1995-03-16 Zeneca Limited Fungicides
DE19548825C2 (de) * 1995-12-27 1999-03-25 Rolf Dr Hermann Neue, substituierte Cyclopentylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19604225A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Stoffzusammensetzungen aus alpha-Aminosäuren und Cyclohexen-beta-aminosäuren

Also Published As

Publication number Publication date
IL118869A0 (en) 1996-10-31
CU22820A3 (es) 2003-01-29
NZ299008A (en) 1998-05-27
YU41796A (sh) 1999-06-15
SG47158A1 (en) 1998-03-20
EP0754678A2 (de) 1997-01-22
SI0754678T1 (en) 2001-04-30
SV1996000062A (es) 1997-06-26
AU5948896A (en) 1997-01-23
HUP9601977A2 (en) 1997-05-28
CO4700525A1 (es) 1998-12-29
EE9600109A (et) 1997-02-17
MA23940A1 (fr) 1997-04-01
GR3035601T3 (en) 2001-06-29
HU9601977D0 (en) 1996-09-30
JP2007056026A (ja) 2007-03-08
CZ288204B6 (en) 2001-05-16
UA46725C2 (uk) 2002-06-17
DK0754678T3 (da) 2001-02-05
CN1115145C (zh) 2003-07-23
SK281850B6 (sk) 2001-08-06
SK94796A3 (en) 1997-02-05
SA96170491B1 (ar) 2006-09-20
RO118656B1 (ro) 2003-08-29
JP3891503B2 (ja) 2007-03-14
BR9603124A (pt) 1998-04-22
CZ287896B6 (cs) 2001-03-14
DE59611398D1 (de) 2006-12-14
PL184861B1 (pl) 2003-01-31
EP0754678B1 (de) 2001-01-03
EP0754678A3 (de) 1997-12-17
YU20050685A (sh) 2006-08-17
BG62134B1 (bg) 1999-03-31
JPH09202761A (ja) 1997-08-05
PE9398A1 (es) 1998-04-15
DK1043332T3 (da) 2007-03-12
US5935988A (en) 1999-08-10
HUP9601977A3 (en) 1998-04-28
TNSN96100A1 (fr) 2005-03-15
HRP960303B1 (en) 2001-08-31
SI1043332T1 (sl) 2007-04-30
IL118869A (en) 2002-03-10
CZ214396A3 (en) 1997-02-12
EP1043332B1 (de) 2006-11-02
HRP960303A2 (en) 1998-02-28
PL315330A1 (en) 1997-01-20
CN1143496A (zh) 1997-02-26
DE59606266D1 (de) 2001-02-08
ZA966111B (en) 1997-02-03
RU2181123C2 (ru) 2002-04-10
NO315926B1 (no) 2003-11-17
TR199600583A2 (tr) 1997-02-21
EP1043332A1 (de) 2000-10-11
DZ2073A1 (fr) 2002-07-22
ES2275460T3 (es) 2007-06-16
HK1005131A1 (en) 1998-12-24
ES2154761T3 (es) 2001-04-16
EE03803B1 (et) 2002-08-15
ATE344274T1 (de) 2006-11-15
MX9602836A (es) 1997-01-31
DE19526274A1 (de) 1997-01-23
NO963000L (no) 1997-01-20
PT1043332E (pt) 2007-01-31
RS49520B (sr) 2006-10-27
CA2181308A1 (en) 1997-01-20
AU713555B2 (en) 1999-12-02
PT754678E (pt) 2001-04-30
KR100433968B1 (ko) 2004-08-30
SK284733B6 (sk) 2005-10-06
ATE198469T1 (de) 2001-01-15
KR970006312A (ko) 1997-02-19
TW496737B (en) 2002-08-01
AR003465A1 (es) 1998-08-05
BG100716A (bg) 1997-04-30

Similar Documents

Publication Publication Date Title
MA24307A1 (fr) Derives d'acides d'arylsulfonylamino-hydroxamiques.
NO2007004I2 (no) Farmasoytisk akseptabelt salt av mykofenolsyre
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
BR9611367A (pt) Formulação farmacêutic liofilizada estável
AU5956196A (en) Methods of increasing accumulation of essential amino acids n seeds
HK1061841A1 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
FI980822A (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
NO992245D0 (no) FremgangsmÕte for fremstilling av aminokarboksylsyrer
AU6257594A (en) Indole derivatives as antagonists of excitatory amino acids
HUP9801838A3 (en) Indole derivatives as antagonists of excitatory amino acids
ATE319685T1 (de) Exzitatorisch wirkende aminosäurederivate
NO963000D0 (no) Bedret fordöyelighet av farmasöytisk virksomme -aminosyrer
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
PL317853A1 (en) Derivatives of amino acids
AU6843498A (en) Process for the preparation of n-(3-hydroxy-succinyl)-amino acid derivatives
IT1283649B1 (it) Procedimento per la preparazione di acidi 2-aril-propionici e 2-aril-acetici a partire da aril-olefine
AP9600854A0 (en) Polymorphs of the pro drug 6 N-(L-ALA-L-ALA) - trovafloxacin
FI972791A0 (fi) Orgaanisten happojen ja aminohappojen valmistus
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer
AU8536398A (en) Incorporation of pharmacologically active amino acid analogues into proteins
SE9503923D0 (sv) New amino acid derivatives
SE9502487D0 (sv) New amino acid derivatives
SE9502503D0 (sv) New amino acid derivatives
SE9502504D0 (sv) New amino acid derivatives
SE9502505D0 (sv) New amino acid derivatives